Details for New Drug Application (NDA): 202026
✉ Email this page to a colleague
The generic ingredient in TRETINOIN is tretinoin. There are twenty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
Summary for 202026
Tradename: | TRETINOIN |
Applicant: | Mylan |
Ingredient: | tretinoin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 202026
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | GEL;TOPICAL | Strength | 0.1% | ||||
Approval Date: | Jul 17, 2013 | TE: | RLD: | No |
Complete Access Available with Subscription